Hello,

We noticed you're browsing in private or incognito mode.

To continue reading this article, please exit incognito mode or log in.

Not an Insider? Subscribe now for unlimited access to online articles.

Katherine Bourzac

A View from Katherine Bourzac

A Brain-Cancer Imaging First

A new imaging nanoparticle capable of crossing the blood-brain barrier might help doctors spot brain tumors during surgery.

  • August 4, 2009

Researchers at the University of Washington, Seattle have made the first imaging nanoparticle that can cross the blood-brain barrier. The nanoparticle, which specifically targets tumor cells, might help surgeons better pinpoint the boundaries of brain tumors.

A new nanoparticle contrast agent gives a clearer picture of a mouse’s brain tumor in both MRI and optical images (left column) than is possible without the agent (right column). The tumor is located in the cerebellum. Credit: Cancer Research

The blood vessels that serve the brain are much more selective about what gets through than those feeding the rest of the body’s organs. This helps protect the brain from infection, but it also makes it difficult to get drugs and image-contrast agents inside the brain. The barrier can be temporarily broached using drugs, but at the risk of infection. This has made it difficult to apply recent developments in the field of molecular imaging, which uses targeted nanoparticles to light up tumor cells, to the brain. Targeted imaging could be particularly useful for imaging brain tumors, since these tend to be very invasive, infiltrating the surrounding brain tissue, making it difficult to remove them without damaging surrounding tissues, leading to cognitive problems.

The Seattle researchers developed a nanoparticle that is visible on magnetic resonance imaging scans and under the near-infrared light used by surgical microscopes. They tuned the particle’s properties–size, fat content, and electrical charge–so that it could cross the blood-brain barrier. It’s made up of an iron-oxide sphere coated with a fluorescent protein and a protein that’s targeted to tumor cells. When administered through a blood vessel to mice carrying brain tumors, the nanoparticle, which is described this week in the journal Cancer Research, improved contrast in brain imaging scans.

Want to go ad free? No ad blockers needed.

Become an Insider
Already an Insider? Log in.
More from Rewriting Life

Reprogramming our bodies to make us healthier.

Want more award-winning journalism? Subscribe to Insider Plus.
  • Insider Plus {! insider.prices.plus !}*

    {! insider.display.menuOptionsLabel !}

    Everything included in Insider Basic, plus the digital magazine, extensive archive, ad-free web experience, and discounts to partner offerings and MIT Technology Review events.

    See details+

    What's Included

    Unlimited 24/7 access to MIT Technology Review’s website

    The Download: our daily newsletter of what's important in technology and innovation

    Bimonthly print magazine (6 issues per year)

    Bimonthly digital/PDF edition

    Access to the magazine PDF archive—thousands of articles going back to 1899 at your fingertips

    Special interest publications

    Discount to MIT Technology Review events

    Special discounts to select partner offerings

    Ad-free web experience

/3
You've read of three free articles this month. for unlimited online access. You've read of three free articles this month. for unlimited online access. This is your last free article this month. for unlimited online access. You've read all your free articles this month. for unlimited online access. You've read of three free articles this month. for more, or for unlimited online access. for two more free articles, or for unlimited online access.